Arteriovenous Fistula Formation using Transposed Basilic Vein: Extensive Single Centre Experience

Abstract

BBAVF represents an important option for vascular access with acceptable patency rates, although complication rates remain significant.

A comparison of the outcomes of one-stage and two-stage brachiobasilic arteriovenous fistulas

“…To date, limited and conflicting data exist regarding primary failure and the patency rates of one-stage and two-stage procedures. [4][5][6][7][8][9][10][11][12] Each procedure has advantages and disadvantages. The one-stage procedure offers the benefits of a single operation with earlier functional patency and possible shorter duration with a central venous catheter.…”

Vascular Access for Dialytic Therapies

“…87.6). 12,[16][17][18][19] In comparison with brachiocephalic fistulas, brachiobasilic AV fistulas are more likely to mature, although they are more susceptible to late thrombosis. However, a randomized study showed similar patencies of brachiocephalic and brachiobasilic AV fistulas.…”

Transposition of brachiobasilic arteriovenous fistulae: improving the cosmetic effect without compromising patency

“…Primary patency for BBAVFs at one year of 72% (range, 23-90%) and at two years of 62% (11-86%) have been quoted. 12,13 These favourable results, coupled with increasing enthusiasm for minimally invasive methods, have generated interest in novel approaches for VAS. Similar methods have been used extensively for harvesting of the saphenous vein in coronary artery bypass grafting.…”

“…16 Reported prevalence of complications for BBAVF remains very high (≥71%). 13,22,23 These complications include large haematomas necessitating surgical evacuation, seromas and wound infection, often resulting from this invasive approach. However, these complications appear to be self-limiting.…”

“…9 Recent series have quoted a prevalence of primary failure of 20% with a primary patency of 70%, though there has been wide variation (23-90%) between series. 12,13 However, this anatomical position offers distinct challenges for obtaining surgical access.…”